Sputnik V said in a statement that the one-shot Sputnik Lite has become the first vaccine to be exported from India, however, its emergency use has not yet been approved in India.
New Delhi: The central government has allowed the export of domestically manufactured Russian single-dose anti-Covid-19 vaccine Sputnik Lite to India. This vaccine has not yet been approved for emergency use in India. The company gave this information on Sunday.Also Read – So far more than 95 crore doses of corona vaccine have been given in India, the figure of 100 will be crossed soon
Sputnik V said in a statement today, “One-shot Sputnik Lite has become the first vaccine to be exported from India. India has become a major manufacturing hub for Sputnik V and Sputnik Lite vaccines through partnership with six major producers set up by RDIF. Also Read – The government told the coal crisis in the country baseless, Manish Sisodia said – the central government is making excuses to “run away” from the crisis
Sources familiar with the development said that Indian pharmaceutical company Hetero Biopharma Ltd has been given permission to export 4 million doses of Sputnik Lite to Russia. Also Read – Government Allows Export Of Russian COVID Vaccine Sputnik Lite Made In India, Only Single Dose…
One-shot Sputnik Light becomes the first vaccine to be allowed to be exported from India. India has become a key manufacturing hub for Sputnik V & Sputnik Light vaccines through partnerships with six leading producers established by RDIF: Sputnik V#COVID19 pic.twitter.com/PGOtrz2O5e
— ANI (@ANI) October 10, 2021
Sputnik Lite is similar to component-1 of the Russian vaccine Sputnik V. India’s drug regulator approved the emergency use of Sputnik V in April, which has since been used in India’s anti-COVID-19 vaccination program.
Russian Ambassador Nikolay Kudshev has urged the Indian government to allow the export of Sputnik Lite, produced by Hetero Biopharma, to Russia until the vaccine is approved for emergency use by the drug regulator in India.
A source said, “The government has allowed Indian pharmaceutical company Hetero Biopharma to export 4 million doses of Sputnik Lite to Russia. The decision was taken this week after detailed deliberations.